Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 8-K (Current Report)
Reporting Date: October 2, 2025 (Earliest event reported)
Event: Entry into a Material Definitive Agreement (Warrant Inducement) and Unregistered Sales of Equity Securities.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.85 million received from the exercise of existing warrants.
- Shares Exercised: 1,429,528 shares of Common Stock purchased by holders.
- Exercise Price (Existing Warrants): Reduced to $2.00 per share.
- Transaction Costs:
- Financial Advisor Cash Fee: 6.0% of aggregate gross proceeds.
- Expense Reimbursement: Up to $20,000.
- Advisor Warrants: Issued for approximately 2.0% of the New Warrant Shares.
- Use of Proceeds: Working capital and general corporate purposes.
Material Changes and New Securities Issued
In consideration for the immediate exercise of existing warrants, the Company issued new securities:
- New Warrants: Issued to holders of the Existing Warrants to purchase up to 1,429,528 shares (100% of shares issued upon exercise).
- New Warrant Terms:
- Exercise Price: $3.00 per share.
- Term: 5 years from issuance.
- Exercisability: Commences after stockholder approval.
- Cashless Exercise: Available if resale registration is not effective after six months.
- Beneficial Ownership Limit: 4.99% (or 9.99% upon election).
- Advisor Warrants: Issued to designees of WallachBeth Capital, LLC to purchase shares equal to ~2.0% of New Warrant Shares at an exercise price of $3.00.
Outlook, Risks, and Contingencies
- Registration Obligations: The Company must file a registration statement for the resale of New Warrant Shares within 15 calendar days of the agreement and use commercially reasonable efforts to have it declared effective.
- Stockholder Approval: The New Warrants are not exercisable until the Company receives stockholder approval.
- Right of First Refusal: WallachBeth Capital, LLC holds a 6-month right of first refusal to participate in future equity and debt offerings.
- Legal Disclaimer: Representations and warranties in the agreement were made solely for the benefit of the parties and should not be relied upon as representing the current state of the Company's affairs.
Investor Verification Checklist
- Verify the status of the Form S-1 registration statement (File No. 333-286331) for the Existing Warrant Shares.
- Confirm the filing and effectiveness of the new Resale Registration Statement for the New Warrant Shares within the 15-day window.
- Monitor for the upcoming stockholder vote required to make the New Warrants exercisable.
- Review the definitive Warrant Inducement Letter (Exhibit 10.1) for specific adjustment formulas and fundamental transaction provisions.
- Assess the impact of the 6.0% advisory fee and issuance of Advisor Warrants on net capital raised.